Gainers

Check out these big penny stock gainers and losers

Losers

• Macquarie Infrastructure Corporation (NYSE:MIC) shares fell 91.1% to $3.58 .
• Allogene Therapeutics, Inc. (NASDAQ:ALLO) shares dipped 43.3% to $13.79 after the company reported the FDA placed a hold on the company's AlloCAR T clinical trials.
• Agile Therapeutics, Inc. (NASDAQ:AGRX) shares fell 29.5% to $0.6645 after the company announced an offering of common stock and warrants.
• Cellectis S.A. (NASDAQ:CLLS) fell 19% to $9.74. Baird downgraded Cellectis from Outperform to Neutral and lowered the price target from $39 to $10.
• Nkarta, Inc. (NASDAQ:NKTX) dipped 13.7% to $21.57. Nkarta updated guidance on initial data readout of Phase 1 trial of NKX101 in relapsed or refractory acute myeloid leukemia or higher-risk myelodysplastic syndromes.
• Caribou Biosciences, Inc. (NASDAQ:CRBU) dropped 11.7% to $19.95.
• Blue Apron Holdings, Inc. (NYSE:APRN) fell 10% to $7.08.
• Omeros Corporation (NASDAQ:OMER) dropped 9.9% to $6.70. JP Morgan downgraded Omeros from Neutral to Underweight.
• Cidara Therapeutics, Inc. (NASDAQ:CDTX) fell 9.6% to $1.69 after the company priced 14.8 million share offering at $1.55 per share.
• Kiromic BioPharma, Inc. (NASDAQ:KRBP) dropped 9.2% to $1.97. Kiromic BioPharma recently named Daniel Clark as interim Chief Financial Officer.
• MaxCyte, Inc. (NASDAQ:MXCT) fell 8.4% to $9.81.
• Sharecare, Inc. (NASDAQ:SHCR) dipped 7.7% to $7.68.
• Lucira Health, Inc. (NASDAQ:LHDX) dipped 7.6% to $6.10. Lucira Health issued a statement on recall of FLOQSwabs by its Italian partner, Copan Italia.
• CareMax, Inc. (NASDAQ:CMAX) dropped 7.2% to $8.18.